The immunology and immunopathology of COVID-19.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
11 03 2022
Historique:
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 19 3 2022
Statut: ppublish

Résumé

Considerable research effort has been made worldwide to decipher the immune response triggered upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, identify the drivers of severe and fatal COVID-19, and understand what leads to the prolongation of symptoms after disease resolution. We review the results of almost 2 years of COVID-19 immunology research and discuss definitive findings and remaining questions regarding our understanding of COVID-19 pathophysiology. We discuss emerging understanding of differences in immune responses seen in those with and without Long Covid syndrome, also known as post-acute sequelae of SARS-CoV-2. We hope that the knowledge gained from this COVID-19 research will be applied in studies of inflammatory processes involved in critical and chronic illnesses, which remain a major unmet need.

Identifiants

pubmed: 35271343
doi: 10.1126/science.abm8108
doi:

Substances chimiques

Antibodies, Monoclonal 0
Antiviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1122-1127

Subventions

Organisme : NCI NIH HHS
ID : P30 CA196521
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI157488
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States

Auteurs

Miriam Merad (M)

Precision Immunology Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Catherine A Blish (CA)

Department of Medicine and Program in Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.

Federica Sallusto (F)

Institute of Microbiology, ETH Zürich, 8093 Zürich, Switzerland.
Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland.

Akiko Iwasaki (A)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH